Literature DB >> 1518810

Phosphorylation of the retinoblastoma protein by cdk2.

T Akiyama1, T Ohuchi, S Sumida, K Matsumoto, K Toyoshima.   

Abstract

The retinoblastoma gene product (the RB protein) is phosphorylated in a cell cycle-dependent manner and this modification is believed to be important for cells to progress through the cell cycle. We found that purified cdk2 (cyclin-dependent kinase/cell division kinase 2) can phosphorylate the RB protein in vitro at the sites phosphorylated in the cell. The timing of activation of cdk2 in the cell cycle was similar to that of the onset of phosphorylation of the RB protein. The kinase coprecipitated with the RB protein also exhibited a similar substrate specificity to cdk2 and a similar time course of activation during the cell cycle. We further showed that cdk2 formed a complex with the RB protein in vitro and that its formation was not competitively inhibited by the simian virus 40 large T antigen. These observations suggest that cdk2 or a cdk2-related protein is involved in the cell cycle-dependent phosphorylation of the RB protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1518810      PMCID: PMC49822          DOI: 10.1073/pnas.89.17.7900

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.

Authors:  L R Bandara; N B La Thangue
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

2.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.

Authors:  D W Goodrich; N P Wang; Y W Qian; E Y Lee; W H Lee
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

3.  Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes.

Authors:  F Fang; J W Newport
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

4.  Cloning of a human cDNA encoding a CDC2-related kinase by complementation of a budding yeast cdc28 mutation.

Authors:  J Ninomiya-Tsuji; S Nomoto; H Yasuda; S I Reed; K Matsumoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

Authors:  Y Matsuura; R D Possee; H A Overton; D H Bishop
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

Review 6.  Tumor suppressor genes.

Authors:  R A Weinberg
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

7.  Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A.

Authors:  J Rosenblatt; Y Gu; D O Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

8.  The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.

Authors:  S Bagchi; R Weinmann; P Raychaudhuri
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

9.  A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.

Authors:  S H Devoto; M Mudryj; J Pines; T Hunter; J R Nevins
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

10.  A new human p34 protein kinase, CDK2, identified by complementation of a cdc28 mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Eg1.

Authors:  S J Elledge; M R Spottswood
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

View more
  61 in total

1.  Accumulation of cyclin E is not a prerequisite for passage through the restriction point.

Authors:  S V Ekholm; P Zickert; S I Reed; A Zetterberg
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  Hepatocyte growth factor releases mink epithelial cells from transforming growth factor beta1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity.

Authors:  M Tsubari; J Taipale; E Tiihonen; J Keski-Oja; M Laiho
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  Immunohistochemical study of Cell Cycle Modulators in G(1)-S Transition in Clinical Breast Cancer Tissue.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

5.  Intra-S-phase checkpoint activation by direct CDK2 inhibition.

Authors:  Yonghong Zhu; Carmen Alvarez; Ronald Doll; Hirokazu Kurata; Xiao Min Schebye; David Parry; Emma Lees
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

6.  Stem-cell factor regulates the expression of cyclin A and retinoblastoma gene product in the growth and differentiation pathway of human megakaryocytic cells.

Authors:  E Shimizu; Y Takahashi; A Shinohara; Y Yamamoto; S Yoshida; A Yamamoto; S Sone; Y Takaue; T Ogura
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

7.  The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2.

Authors:  Tarryn Willmer; Jade Peres; Shaheen Mowla; Amaal Abrahams; Sharon Prince
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637.

Authors:  J B Schnier; K Nishi; D W Goodrich; E M Bradbury
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

9.  Covalent Modification of CDK2 by 4-Hydroxynonenal as a Mechanism of Inhibition of Cell Cycle Progression.

Authors:  Jeannie M Camarillo; Kristie L Rose; James J Galligan; Shu Xu; Lawrence J Marnett
Journal:  Chem Res Toxicol       Date:  2016-03-11       Impact factor: 3.739

10.  Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression.

Authors:  E S Knudsen; C Buckmaster; T T Chen; J R Feramisco; J Y Wang
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.